Compounds > cp-55,940
Page last updated: 2024-08-26

cp-55,940 and Ache

cp-55,940 has been researched along with Ache in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG1
Astles, PC; Chambers, MG; Hollinshead, SP; Johnson, MP; Palmer, J; Tidwell, MW1
Aiello, F; Brizzi, A; Brizzi, V; Cascio, MG; Corelli, F; De Petrocellis, L; Di Marzo, V; Lamponi, S; Ligresti, A; Luongo, L; Maione, S; Marini, P; Pertwee, RG1
Al-Shamma, H; Behan, DP; Chen, C; Chen, R; Choi, K; Dang, H; Decaire, M; Edwards, J; Fu, L; Gaidarov, I; Gatlin, J; Han, S; Jones, RM; Jung, JK; Morgan, M; Narayanan, S; Pride, C; Sadeque, A; Semple, G; Solomon, M; Strah-Pleynet, S; Thatte, J; Thoresen, L; Unett, DJ; Usmani, KA; Whelan, K; Xiong, Y; Yue, D; Zhu, X1

Other Studies

4 other study(ies) available for cp-55,940 and Ache

ArticleYear
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
    Journal of medicinal chemistry, 2008, Nov-27, Volume: 51, Issue:22

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship

2008
Discovery and optimization of novel purines as potent and selective CB2 agonists.
    Bioorganic & medicinal chemistry letters, 2012, Aug-01, Volume: 22, Issue:15

    Topics: Animals; Drug Evaluation, Preclinical; Furans; Half-Life; Humans; Pain; Purines; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship

2012
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
    Bioorganic & medicinal chemistry, 2014, Sep-01, Volume: 22, Issue:17

    Topics: Analgesics; Animals; Calcium Channels; Cell Survival; Cells, Cultured; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Humans; Ligands; Male; Mice; Molecular Structure; Nerve Tissue Proteins; NIH 3T3 Cells; Nociception; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Structure-Activity Relationship; Transient Receptor Potential Channels; TRPA1 Cation Channel

2014
Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists.
    Bioorganic & medicinal chemistry letters, 2015, Jan-15, Volume: 25, Issue:2

    Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Arthritis, Experimental; Heterocyclic Compounds, 3-Ring; Humans; Inflammation; Male; Microsomes, Liver; Models, Molecular; Molecular Structure; Osteoarthritis; Pain; Pyrazoles; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Stereoisomerism; Structure-Activity Relationship

2015